The Business Gazette Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Business Gazette Online.

Press releases published on October 1, 2026

WISeKey’s Redomiciliation from Switzerland to the British Virgin Islands Becomes Legally Effective
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AsiaStrategy Signs Memorandum of Understanding with Plume Network to Advance Real-World Asset Tokenisation Across Asia
Robinhood Markets, Inc. to Announce Third Quarter 2026 Results on October 27, 2026
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nasdaq to Hold Third Quarter 2026 Investor Conference Call
Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026
Trasteel Holding S.A. and Sizzle Acquisition Corp. II Announce Confidential Submission of Draft Registration Statement on Form F-4 in Connection with the Proposed Business Combination
Digital Realty Schedules Third Quarter 2026 Earnings Release and Conference Call
TFI International to Release Third Quarter 2026 Results
TFI International publiera ses résultats du troisième trimestre de 2026
Liquidity Services Acquires Invaluable Marketplace
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
Financial Institutions, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Fluence Energy, Inc. and Encourages Investors to Contact the Firm
Healthy Moms, Healthy Babies America (HMHBA) Announces $20 Million in State Grants for Arkansas and Kentucky
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Business Gazette Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.